---
title: "Fenofibrate - Hypoalphalipoproteinemia"
sidebar: mydoc_sidebar
permalink: db01039-mesh-d052456-1.html
toc: false 
---


Path ID: `DB01039_MESH_D052456_1`
{% include image.html url="images/db01039-mesh-d052456-1.png" file="db01039-mesh-d052456-1.png" alt="db01039-mesh-d052456-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D011345 | Fenofibrate | Drug |
| MESH:C006012 | Fenofibric acid | Drug |
| UniProt:Q07869 | Peroxisome proliferator-activated receptor alpha | Protein |
| MESH:D008075 | Lipoproteins, HDL | ChemicalSubstance |
| MESH:D052456 | Hypoalphalipoproteinemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Fenofibrate | HAS METABOLITE | Fenofibric Acid |
| Fenofibric Acid | INCREASES ACTIVITY OF | Peroxisome Proliferator-Activated Receptor Alpha |
| Peroxisome Proliferator-Activated Receptor Alpha | INCREASES ABUNDANCE OF | Lipoproteins, Hdl |
| Lipoproteins, Hdl | NEGATIVELY CORRELATED WITH | Hypoalphalipoproteinemia |
|---------|-----------|---------|

Comment: Fenofibrate is pharmacologically inactive prodrug which undergoes rapid hydrolysis at the ester bond to form the active metabolite fenofibric acid.

Reference: 
  - [https://go.drugbank.com/drugs/DB01039](https://go.drugbank.com/drugs/DB01039)
  - [https://en.wikipedia.org/wiki/Hypoalphalipoproteinemia](https://en.wikipedia.org/wiki/Hypoalphalipoproteinemia)
